GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rakovina Therapeutics Inc (OTCPK:RKVTD) » Definitions » Purchase Of Business

RKVTD (Rakovina Therapeutics) Purchase Of Business : $0.00 Mil (TTM As of Mar. 2025)


View and export this data going back to 2024. Start your Free Trial

What is Rakovina Therapeutics Purchase Of Business?

Rakovina Therapeutics's purchase of business for the three months ended in Mar. 2025 was $0.00 Mil. It means Rakovina Therapeutics spent $0.00 Mil on purchasing business. Rakovina Therapeutics's purchase of business for the trailing twelve months (TTM) ended in Mar. 2025 was $0.00 Mil.

Compared with last quarter ($0.00 Mil in Dec. 2024 ), Rakovina Therapeutics spent the same money on purchasing business in Mar. 2025 ($0.00 Mil).

Rakovina Therapeutics Purchase Of Business Historical Data

The historical data trend for Rakovina Therapeutics's Purchase Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rakovina Therapeutics Purchase Of Business Chart

Rakovina Therapeutics Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Purchase Of Business
- - - -

Rakovina Therapeutics Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Purchase Of Business Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Rakovina Therapeutics Purchase Of Business Calculation

The amount used to purchase business.

Purchase Of Business for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rakovina Therapeutics Purchase Of Business Related Terms

Thank you for viewing the detailed overview of Rakovina Therapeutics's Purchase Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.

Rakovina Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rakovina Therapeutics Inc (OTCPK:RKVTD) » Definitions » Purchase Of Business
Comparable Companies
TSX:CSCI TSXV:SHRX XCNQ:BETR TSXV:IOT XCNQ:MDMA TSX:RVX XCNQ:PREV XCNQ:TELI XCNQ:BIOV XCNQ:BLAB VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:UCB XBRU:ARGX ONC XKRX:068270 BNTX
Traded in Other Exchanges
RKV:Canada
Address
105 1008 Beach Avenue, Vancouver, BC, CAN, V6E 1T7
Website
https://www.rakovinatherapeutics.com
Rakovina Therapeutics Inc is a biopharmaceutical research company focused on the development of cancer treatments. Its work is based on technologies for targeting the DNA-damage response powered by Artificial Intelligence (AI) using proprietary, generative AI platforms. By using AI, it can review and optimize drug candidates at a much greater pace than ever before. The company has established a pipeline of distinctive DNA-damage response inhibitors with the goal of advancing one or more drug candidates into human clinical trials in collaboration with pharmaceutical partners.